Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × tasquinimod × Clear all

NCT02159950 2023-04-27

Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Phase 2 Completed

2 enrolled 7 charts

Prostatic Neoplasms

NCT00560482 2015-10-26

Efficacy Study of ABR-215050 to Treat Prostate Cancer

Phase 2 Completed

Neoplasms, Prostatic Neoplasms